azathioprine has been researched along with transforming growth factor beta in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 9 (69.23) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Beck, J; Jullien, P; Lawrence, DA; Rondot, P; Wietzerbin, J | 1 |
| de Kuiper, P; IJzermans, JN; Vaessen, LM; van Besouw, NM; van der Mast, BJ; van Gelder, T; Weimar, W | 1 |
| Hamar, P; Heemann, U; Liu, S; Múller, V; Szabó, A; Viklický, O | 1 |
| Grabensee, B; Heering, P; Hetzel, GR; Ozcan, F; Plum, J | 1 |
| Anarat, A; Bayazit, AK; Bayazit, Y; Gonlusen, G; Noyan, A | 1 |
| Alberú, J; Chew-Wong, A; Correa-Rotter, R; de Leo, C; Guzmán-Rodríguez, H; Llorente, L; Mancilla, E; Richaud-Patin, Y; Vázquez-Lavista, LG | 1 |
| Böhler, T; Budde, K; Einecke, G; Eljazyfer, S; Glander, P; Neumayer, HH; Schneider, M; Slowinski, T; Waiser, J | 1 |
| Bolgert, F; Debré, P; Le Garff-Tavernier, M; Leblond, V; Morel, V; Nguyen, S; Vieillard, V | 1 |
| Beaumont, BW; Copeland, JW; Merrilees, MJ; Pilmore, HL | 1 |
| Denton, CP; Quillinan, NP | 1 |
| de Boer, NK; Jharap, B; Klimesova, K; Kverka, M; Lukas, M; Mulder, CJ; Rossmann, P; Tlaskalova-Hogenova, H; van Bodegraven, AA; Vos, RM | 1 |
| Dębska-Ślizień, A; Imko-Walczuk, B; Piesiaków, ML; Pikuła, M; Rutkowski, B; Trzonkowski, P | 1 |
| Cardoso, CG; Carneiro, CC; Chen-Chen, L; da Silva Santos, AF; de Melo Bisneto, AV; Fernandes, AS; Silveira-Lacerda, EP; Soares, ETS; Velozo Sá, VS; Véras, JH | 1 |
1 review(s) available for azathioprine and transforming growth factor beta
| Article | Year |
|---|---|
Disease-modifying treatment in systemic sclerosis: current status.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Autoantigens; Azathioprine; Collagen Type I; Connective Tissue Growth Factor; Cyclophosphamide; Evidence-Based Practice; Fibrosis; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Plasmapheresis; Rituximab; Scleroderma, Systemic; Transforming Growth Factor beta; Transplantation, Autologous; Tumor Necrosis Factor-alpha | 2009 |
2 trial(s) available for azathioprine and transforming growth factor beta
| Article | Year |
|---|---|
A longitudinal study of TGF-beta1 protein levels in renal allograft recipients converted from CsA to MMF or AZA.
Topics: Azathioprine; Creatinine; Cyclosporine; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Longitudinal Studies; Mycophenolic Acid; Transforming Growth Factor beta | 2000 |
Profibrotic cytokines and lymphocyte proliferation in stable renal allograft recipients treated with or without cyclosporine A.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Azathioprine; CD3 Complex; Cell Proliferation; Creatine; Cyclosporine; Cytokines; Drug Monitoring; Endothelin-1; Female; Humans; Immune System; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Leukocytes, Mononuclear; Linear Models; Lymphocytes; Male; Methylprednisolone; Middle Aged; Transforming Growth Factor beta; Transforming Growth Factor beta1; Transplantation, Homologous; Treatment Outcome | 2006 |
10 other study(ies) available for azathioprine and transforming growth factor beta
| Article | Year |
|---|---|
TGF-beta-like activity produced during regression of exacerbations in multiple sclerosis.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Azathioprine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multiple Sclerosis; Neurologic Examination; Transforming Growth Factor beta | 1991 |
Cyclosporine A and azathioprine are equipotent in chronic kidney allograft rejection.
Topics: Animals; Azathioprine; Chronic Disease; Cyclosporine; Glomerulosclerosis, Focal Segmental; Graft Rejection; Immunosuppressive Agents; Kidney; Kidney Transplantation; Leukocytes; Male; Polymerase Chain Reaction; Rats; Rats, Inbred F344; Rats, Inbred Lew; Receptors, Interleukin-2; RNA, Messenger; Transforming Growth Factor beta | 2000 |
Transforming growth factor-beta1 plasma levels in stable renal allograft recipients under different immunosuppression.
Topics: Adult; Azathioprine; Biopsy; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Steroids; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2001 |
Comparison of mycophenolate mofetil and azathioprine in obstructive nephropathy.
Topics: Animals; Azathioprine; Collagen; Fibronectins; Fibrosis; Immunohistochemistry; Kidney Diseases; Mycophenolic Acid; Rats; Rats, Wistar; Transforming Growth Factor beta; Ureteral Obstruction | 2003 |
In vivo IL-10 and TGF-beta production by PBMC from long-term kidney transplant recipients with excellent graft function: a possible feedback mechanism participating in immunological stability.
Topics: Adult; Aged; Azathioprine; Cells, Cultured; Cross-Sectional Studies; Enzyme-Linked Immunosorbent Assay; Female; Graft Survival; Humans; Immunosuppressive Agents; Interleukin-10; Kidney; Kidney Transplantation; Leukocytes, Mononuclear; Male; Middle Aged; Prednisone; Transforming Growth Factor beta | 2004 |
Persistence of CD16+/CD56-/2B4+ natural killer cells: a highly dysfunctional NK subset expanded in ocular myasthenia gravis.
Topics: Aged; Anti-Inflammatory Agents; Antigens, CD; Azathioprine; CD56 Antigen; Cholinesterase Inhibitors; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukin-18; Killer Cells, Natural; Lymphocyte Subsets; Male; Membrane Glycoproteins; Myasthenia Gravis; Phenotype; Pyridostigmine Bromide; Receptors, IgG; Receptors, Immunologic; Signaling Lymphocytic Activation Molecule Family; Transforming Growth Factor beta | 2006 |
Epithelial-to-mesenchymal transition of human proximal tubular epithelial cells: effects of rapamycin, mycophenolate, cyclosporin, azathioprine, and methylprednisolone.
Topics: Actins; Azathioprine; Cell Differentiation; Cell Proliferation; Cells, Cultured; Cyclosporine; Epithelial Cells; Fibroblasts; Humans; Immunosuppressive Agents; Kidney Transplantation; Kidney Tubules, Proximal; Methylprednisolone; Mycophenolic Acid; Sirolimus; Transforming Growth Factor beta; Versicans | 2007 |
Safety and efficacy of the immunosuppressive agent 6-tioguanine in murine model of acute and chronic colitis.
Topics: Acute Disease; Alanine Transaminase; Analysis of Variance; Animals; Apoptosis; Azathioprine; Chronic Disease; Colitis; Colon; Dextran Sulfate; Female; Interferon-gamma; Interleukin-6; Liver; Mice; Mice, Inbred BALB C; Models, Animal; T-Lymphocytes, Helper-Inducer; Thioguanine; Transforming Growth Factor beta; Weight Loss | 2011 |
Associations of Selected Cytokines Levels in Organ Transplant Recipients Without and With Malignant Skin Neoplasms.
Topics: Adult; Azathioprine; Case-Control Studies; Cyclosporine; Cytokines; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukin-10; Interleukin-2; Male; Middle Aged; Mycophenolic Acid; Organ Transplantation; Postoperative Complications; Skin Neoplasms; Transforming Growth Factor beta | 2016 |
Anti-angiogenic activity of azathioprine.
Topics: Angiogenesis Inhibitors; Animals; Azathioprine; Blood Vessels; Chick Embryo; Chorioallantoic Membrane; Neovascularization, Physiologic; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2021 |